Home › Autism Spectrum Disorder › NCT05590715

International Multicentric Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

International, Multicentric, Observational Study to Characterize Subpopulations of Patients With Autism Spectrum Disorder

Who can join

Ages 12 to 65 · All sexes

Inclusion Criteria:

* Participants previously diagnosed with ASD (DSM-5)
* Available well-documented health records within the first 2 years of life
* Participants must have a parent or reliable caregiver who agrees to provide information about the participant
* Participants willing and consenting or assenting to participate.

Exclusion Criteria:

* Episode of fever (i.e. ≥100.5 °F or ≥ 38 °C) or clinically significant illness without fever (as judged by the investigator), within 10 days before any study assessment.
* If the investigator assesses any unwillingness or any medical condition that may prevent the subject from completing this study.

About the study

To determine sufficient number of biological and clinical markers to identify subgroups of potential best responders to a specific medication

Sponsor: Stalicla SA · Participants: 1,500 · Started: Oct 13, 2022

Contact the study team

• Eric Painbeni, PhD · Phone: +41 22 545 12 42

Official record on ClinicalTrials.gov — NCT05590715

Locations in the U.S.

Conditions

• Autism Spectrum Disorder

From ClinicalTrials.gov, data retrieved Oct 3, 2026. Each study sets its own eligibility; the study team decides who can join.